DE

470.26

-1.59%↓

FDX

245.41

+1.56%↑

PAYX

155.09

+0.39%↑

CPRT

57.56

+0.61%↑

HEICA

212.9

+0.18%↑

DE

470.26

-1.59%↓

FDX

245.41

+1.56%↑

PAYX

155.09

+0.39%↑

CPRT

57.56

+0.61%↑

HEICA

212.9

+0.18%↑

DE

470.26

-1.59%↓

FDX

245.41

+1.56%↑

PAYX

155.09

+0.39%↑

CPRT

57.56

+0.61%↑

HEICA

212.9

+0.18%↑

DE

470.26

-1.59%↓

FDX

245.41

+1.56%↑

PAYX

155.09

+0.39%↑

CPRT

57.56

+0.61%↑

HEICA

212.9

+0.18%↑

DE

470.26

-1.59%↓

FDX

245.41

+1.56%↑

PAYX

155.09

+0.39%↑

CPRT

57.56

+0.61%↑

HEICA

212.9

+0.18%↑

Enovis Corp

Затворен

СекторИндустриални

37.01 -0.48

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

34.46

Максимум

37.17

Ключови измерители

By Trading Economics

Приходи

-672M

-703M

Продажби

56M

561M

EPS

0.98

Марж на печалбата

-125.353

Служители

7,367

EBITDA

-602M

-590M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+68.67% upside

Дивиденти

By Dow Jones

Следващи печалби

1.05.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-445M

2.2B

Предишно отваряне

37.49

Предишно затваряне

37.01

Настроения в новините

By Acuity

25%

75%

79 / 468 Класиране в Industrials

Enovis Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

7.01.2025 г., 23:28 ч. UTC

Значими двигатели на пазара

Maplebear Up on S&P MidCap 400 Inclusion

Сравнение с други в отрасъла

Ценова промяна

Enovis Corp Прогноза

Ценова цел

By TipRanks

68.67% нагоре

12-месечна прогноза

Среден 62.71 USD  68.67%

Висок 75 USD

Нисък 46 USD

Според 8 анализатори от Wall Street, предложили 12-месечна ценова цел за Enovis Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

8 ratings

7

Купи

1

Задържане

0

Продай

Настроение

By Acuity

79 / 468 Класиране в Индустриални

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Среден

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Enovis Corp

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.